BioSpace News Archive

Extraction Agreement to enable next generation of premium vaporization experiences leveraging Tantalus Labs’ Sungrown product range

Neovasc Inc. announced that the European Heart Journal, Quality of Care and Clinical Outcomes has published a peer-reviewed article indicating the cost effectiveness of the Neovasc Reducer™ as an effective therapy for patients suffering from refractory angina, and its positive impact on healthcare burden.

Funds to Be Used for Commercial Acceleration and Global Launch of Breakthrough HeartLight® X3 System

Medeor Therapeutics, Inc. announced the appointment of Dr. Karen Smith MD., PhD., as its President and Chief Executive Officer.

Shell Oil Company and the National Science Teachers Association announced the grand prize winner and four national finalists in the seventh annual national Shell Science Lab Challenge.

White Oak Healthcare Finance, LLC announced it acted as sole lead arranger on the funding of a senior credit facility to refinance United Medical Systems, Inc., a portfolio company of New State Capital.

Bio-Techne announced the publication of a recent validation study demonstrating that the proprietary exosome-based liquid biopsy tests from Bio-Techne’s Exosome Diagnostics brand may be used to assess the mutational status of the Epidermal Growth Factor Receptor gene in patients with non-small cell lung cancer.

Pharmaceutical Product Development, LLC won multiple honors in the annual PharmaTimes Clinical Researcher of the Year competitions, with 16 PPD clinical research professionals recognized by industry peers for their expertise in the enterprise of drug development.

The American Association of Kidney Patients and the George Washington University School of Medicine & Health Sciences Division of Kidney Diseases and Hypertension hosted the Inaugural Global Summit on Innovations in Patient-Centered Kidney Care on May 21-23, 2019 at the George Washington University campus in Washington, D.C. AAKP is the largest and oldest fully independent patient education and advocacy organization in the United States.

The global external nasal dilator market is expected to post a CAGR of more than 5% during the period 2019-2023, according to the latest market research report by Technavio.